Department of Microbiology, Government Medical College Hospital, Chandigarh, India.
Infect Disord Drug Targets. 2021;21(1):84-89. doi: 10.2174/1871526520666200128162646.
The members of the tribe Proteeae, Morganella and Providencia are being increasingly recognized as important pathogens. The spectrum of disease caused by them is wide and in reported cases, the mortality is high. Previously both of these pathogens were considered to be rare pathogens as the potential to cause nosocomial transmission and infection was not much studied. But their phenomenal evolution and increase in multidrug-resistance (MDR) strains of these pathogens are posing a major threat toward public health throughout the world.
This present study was carried out from July 2018 to December 2018 on all the pus and body fluid samples that were received in the Department of Microbiology. Samples were processed as per the standard Microbiological guidelines and also were analyzed for their antimicrobial susceptibility profile as per Clinical Laboratory Standards Institute.
Out of 8425 samples received, 2140 were culture positive, amongst which 19 samples (0.89%) were positive for Providencia species (9) and Morganella morganii(10). The male : female ratio of these 19 patients was 2.8 : 1 and maximum patients (13) belonged to 20-60 years. As far as risk factors are concerned, maximum patients were diabetics (7) followed by abnormal liver function tests (6), concomitant UTI (6), history of invasive procedure (5), prior exposure to antibiotics (5) and urinary catheterization (4). About 6 were polymicrobial infections. Antibiotic susceptibility patterns revealed that Providencia strains were sensitive to ampicillin- sulbactum (77.7%) and amikacin (77.7%), while all Morganella strains were 100% sensitive to tobramycin and piperacillintazobactam.
This study heralds in need for more research in this area as infections caused by these two pathogens are on the rise. Moreover, resistance to antimicrobials is also an increasingly common problem thus delaying the treatment and prognosis of the disease.
Proteeae 部落的成员摩根菌属和普罗威登斯菌属正日益被认为是重要的病原体。它们引起的疾病谱很广,在报道的病例中,死亡率很高。以前,这两种病原体都被认为是罕见的病原体,因为它们引起医院内传播和感染的潜力没有得到太多研究。但它们的显著进化以及这些病原体多药耐药(MDR)菌株的增加,对全球公共健康构成了重大威胁。
本研究于 2018 年 7 月至 2018 年 12 月在微生物学系接收的所有脓液和体液样本上进行。样本按照标准微生物学指南进行处理,并按照临床实验室标准协会进行分析其抗菌敏感性谱。
在收到的 8425 个样本中,2140 个样本培养阳性,其中 19 个样本(0.89%)为普罗威登斯菌属(9 个)和摩根摩根菌(10 个)阳性。这 19 名患者的男女比例为 2.8:1,最大患者(13 名)年龄在 20-60 岁之间。就危险因素而言,最大患者是糖尿病患者(7 名),其次是肝功能异常(6 名)、同时患有尿路感染(6 名)、有侵入性操作史(5 名)、先前接触过抗生素(5 名)和导尿(4 名)。约 6 例为混合感染。抗生素敏感性模式表明,普罗威登斯菌属菌株对氨苄西林-舒巴坦(77.7%)和阿米卡星(77.7%)敏感,而所有摩根菌属菌株对妥布霉素和哌拉西林-他唑巴坦 100%敏感。
本研究预示着需要在这一领域进行更多的研究,因为这两种病原体引起的感染正在增加。此外,对抗微生物药物的耐药性也是一个日益普遍的问题,从而延迟了疾病的治疗和预后。